Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemzin Biotox Research Institute is an independent Indian contract research organization specializing in preclinical safety assessment and toxicology studies for pharmaceuticals, biologics, medical devices, agrochemicals, industrial chemicals, nutraceuticals/dietary supplements and cosmetics. The institute offers in vivo and in vitro toxicology services under GLP standards with collaborations spanning government and non-government organizations. It does not develop its own clinical pipeline but supports clients' R&D programs through advanced laboratory infrastructure and multidisciplinary expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemzin Biotox Research Institute.